FAM3C and neoplasm: After treatment with SP600125, an inhibitor for JNK signaling, the expression of E-cad, Vim, ZEB1 and Snail mediated by FAM3C was reversed, suggesting that FAM3C promotes tumor cell EMT via JNK-ZEB1/Snail signaling activation (Figure 3L, s4J).